ArticlePloS one2026
Deep feature optimization using fusion of multiple self-supervised learning approaches and filter-based feature selection for lung cancer histopathology classification.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
One of the most deadly illnesses in the world is lung cancer, and increasing survival rates require early detection. Lung cancer diagnostics from the imaging modalities is always subjective, and this paves the way for deep learning assisted computer aided techniques. Still, the accuracy of such a technique is the major concern. This research work attempts to enhance lung cancer diagnostics from histopathological images using a previously unaddressed combination of multiple self-supervised learning techniques, filter-based feature selection, and Vision Graph Convolutional Networks. The main contribution lies in optimized feature fusion, and it brings complementary strengths of three different self-supervised learning approaches- contrastive alignment, redundancy reduction, and semantic grouping. The first step involves extracting the key features from histopathological images using a custom Convolutional Neural Network. Three complementary self-supervised learning methods - Deep Cluster, Bootstrap Your Own Latent, and Simple Framework for Contrastive Learning of Visual Representations - are then used to refine each of these features separately. Following optimization, the improved features are combined, and the most significant features from the combined set are found and preserved using a filter-based feature selection technique called Minimum Redundancy Maximum Relevance. Vision Graph Convolutional Neural Network is used as a classifier. Initial experiments are carried out on the 691 histopathological images extracted from the publicly available LungHist700 dataset. This dataset contains histopathological images under three categories: 151 normal subjects, 280 lung adenocarcinoma subjects, and 260 lung squamous cell carcinoma subjects. The proposed approach provided a balanced accuracy of 97% while the plain Vision Graph Convolution Neural Network offers only an 86% balanced accuracy score. Further validation is performed using two more publicly available datasets, namely LC25000 and TCGA UT datasets. The experimental results demonstrate the enhanced lung cancer prediction performance of the proposed approach in all three datasets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.